Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life

References

• Portenoy RK. Cancer pain. Epidemiology and syndromes. Cancer 1989; 63:2298–307
   Google Scholar
• Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592–6
   PubMed Web of Science ®Google Scholar
• Twycross RG. Optimal pharmacological control of chronic cancer pain. Recent Results Cancer Res 1988;108:9–17
   PubMedGoogle Scholar
• Mohide EA, Royle JA, Montemuro M, et al. Assessing the quality of cancer pain management. J Palliat Care 1988;4:9–15
   PubMedGoogle Scholar
• Grossman SA. Undertreatment of cancer pain: barriers and remedies. Support Care Cancer 1993;1:74–8
   PubMed Web of Science ®Google Scholar
• Galasko CS. Skeletal metastases. Clin Orthop 1986;18–30
   PubMed Web of Science ®Google Scholar
• Lote K, Walloe A, Bjersand A. Bone metastasis. Prognosis, diagnosis and treatment. Acta Radiol Oncol 1986;25:227–32
   PubMedGoogle Scholar
• Cancer pain relief and palliative care. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1990;804:1–75
   PubMedGoogle Scholar
• Cherny NI, Foley KM. Nonopioid and opioid analgesic pharmacotherapy of cancer pain. Hematol Oncol Clin North Am 1996;10:79–102
   PubMed Web of Science ®Google Scholar
• Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med 1996;335:1124–32
   PubMed Web of Science ®Google Scholar
• McQuay HJ, Carroll D, Moore RA. Radiotherapy for painful bone metastases: a systematic review. Clin Oncol (R Coll Radiol) 1997;9:150–4
   PubMedGoogle Scholar
• Hoskin PJ. Radiotherapy for bone pain. Pain 1995;63:137–9
   PubMed Web of Science ®Google Scholar
• McEwan AJ. Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol 2000;10:103–14
   PubMed Web of Science ®Google Scholar
• Forman S. Surgeons and general practitioners - do they ever meet? Clin Oncol 1984;10:5–9
   PubMed Web of Science ®Google Scholar
• Pistevou-Gombaki K, Eleftheriadis N, Sofroniadis I, Makris P, Kouloulias V. Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate. J Exp Clin Cancer Res 2002;21:429–32
   Google Scholar
• Portenoy RK, Southam MA, Gupta SK, Lapin J, Layman M, Inturrisi CE, et al. Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology 1993;78:36–43
   Google Scholar
• Kongsgaard UE, Poulain P. Transdermal fentanyl for pain control in adults with chronic cancer pain. Eur J Pain 1998;2:53–62
   PubMed Web of Science ®Google Scholar
• Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168–75
   PubMed Web of Science ®Google Scholar
• Vielvoye-Kerkmeer AP, Mattern C, Uitendaal MP. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine. J Pain Symptom Manage 2000;19:185–92
   Google Scholar
• Yeo W, Lam KK, Chan AT, Leung TW, Nip SY, Johnson PJ. Transdermal fentanyl for severe cancer related pain. Palliat Med 1997;11:233–9
   PubMed Web of Science ®Google Scholar
• Lehmann K, Zech D. Transdermal fentanyl: clinical pharmacology. J Pain Symptom Manage 1992;(Suppl 7):S8–16
   Google Scholar
• Perry GF. Fentanyl in the treatment of cancer pain. Semin Oncol 1997;24 (5 Suppl 16): S16–20, S16–27
   Google Scholar
• Hammack JE, Mailliard JA, Loprinzi CL, et al. Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage 1996;12:234–40
   PubMed Web of Science ®Google Scholar
• Kongsgaard UE, Poulain P. Transdermal fentanyl for pain control in adults with chronic cancer pain. Eur J Pain 1998;2:53–62
   PubMed Web of Science ®Google Scholar
• Sloan PA, Moulin DE, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998;16:102–11
   PubMed Web of Science ®Google Scholar
• Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168–75
   PubMed Web of Science ®Google Scholar
• Mystakidou K, Mendoza T, Tsilika E, et al. Greek brief pain inventory: validation and utility in cancer pain. Oncology 2001;60:35–42
   PubMed Web of Science ®Google Scholar
• Siegel S. and Castellan NJ Jr. Nonparametric Statistics for the Behavioral Sciences. New York: McGraw Hill, 1988
   Google Scholar
• Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 1999;17:2971–94
   PubMed Web of Science ®Google Scholar
• Nilsen OS, Munro AJ, Tannock F. Bone metastases: pathophysiology and management policy. J Clin Oncol 1986;68: 308–12
   Google Scholar
• Payne R. Mechanisms and management of bone pain. Cancer 1997;80:1608–13
   PubMed Web of Science ®Google Scholar
• Foley KM. The treatment of cancer pain. N Engl J Med 1985;313:84–95
   PubMed Web of Science ®Google Scholar
• Roth AJ, Kornblith AB, Batel-Copel L, et al. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer 1998;82:1904–8
   Google Scholar
• Janjan NA, Martin C, Weissman D, Hill CS, Payne R. Radiotherapy residents’ knowledge of and attitudes toward management of cancer pain. J Cancer Educ 1998;13:65–70
   PubMedGoogle Scholar
• van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WWA. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr Med Res Opin 2003;19:457–69
   PubMed Web of Science ®Google Scholar